Japanese Pharma Sponsored Symposia - Industry Sessions

Please click on the company name in order to view the full session program 



 
Supporter
Date
Session TimeLocation
Language
1
Janssen Pharmaceutical K.K.
Sunday, September 17
12:55-14:40
Room A
English
2
Sumitomo Dainippon Pharma
Sunday, September 17 
12:55-14:40
Annex Hall 2
Translated to English
3
Novartis
Sunday, September 17 12:55-13:45Room DEnglish
4Alexion
Sunday, September 1712:55-13:45
Room ETranslated 
to English
5Medtronic
Sunday, September 17 
12:55-13:45Room B-1Japanese 
6Eisai Co., LtdSunday, September 1712:55-13:45Room B-2English
7Mylan EPD
Sunday, September 17 13:50-14:40Room DJapanese 
8GlaxoSmithKline
Sunday, September 1713:50-14:40Room EEnglish
9Novartis
Sunday, September 17 13:50-14:40Room B-1Japanese 
10Otsuka Pharmaceutical Co., Ltd. / UCB Japan
Sunday, September 1713:50-14:40Room B-2Japanese 
11GlaxoSmithKline
Monday, September 1812:55-13:45Annex Hall 2English
12Eli Lilly
Monday, September 18
12:55-13:4
Room D 

Japanese 
13Mitsubishi Tanabe Pharma Corporation
Monday, September 1812:55-13:45Room EEnglish
14Pfizer Japan Inc.
Monday, September 1812:55-13:45Swan HallEnglish
15Daiichi-Sankyo
Monday, September 1812:55-13:45Room B-1Japanese 
16Nihon Medi-Physics Co., Ltd.
Monday, September 1812:55-13:45Room B-2English
17GlaxoSmithKline
Monday, September 1813:50-14:40Annex Hall 2English
18Bayer Yakuhin, Ltd
Monday, September 1813:50-14:40Room DTranslated 
to English
19Medtronic
Monday, September 1813:50-14:40Room EEnglish
20Pfizer Japan Inc. / Eisai Co., LtdMonday, September 1813:50-14:40Swan HallJapanese 
21Ono Pharmaceutical
Monday, September 1813:50-14:40Room B-1English
22InSightec Japan
Monday, September 1813:50-14:40Room B-2Japanese 
23Takeda Pharmaceutical
Tuesday, September 19
12:55-13:45
Annex Hall 2 
Translated to English 
24Mitsubishi Tanabe Pharma Corporation
Tuesday, September 1912:55-14:40Room DEnglish
25Pfizer Japan Inc.
Tuesday, September 19 12:55-13:45Room EJapanese 
26Bristol-Myers Squibb / Pfizer Japan Inc.
Tuesday, September 1912:55-13:45Swan HallTranslated 
to English
27Nihon Pharmaceutical Co.,LTD.
Tuesday, September 1912:55-13:45Room B-1English
28Daiichi-Sankyo / UCB Japan
Tuesday, September 1912:55-13:45Room B-2Japanese 
29Eli Lilly
Tuesday, September 1912:55-13:45Room H
Japanese 
30Kyowa Hakko Kirin
Tuesday, September 1913:50- 14:40Annex Hall 2Japanese 
31Stryker Japan K.K.
Tuesday, September 19
13:50-14:40
Swan Hall
Translated to English
32Teijin Pharma Limited
Tuesday, September 1913:50- 14:40Room B-1Translated 
to English
33Quanterix Corporation / ScrumTuesday, September 1913:50- 14:40Room B-2English 
34AbbVie GK
Wednesday, September 2012:55-14:40Annex Hall 2English
35Otsuka Pharmaceutical Co., Ltd.Wednesday, September 2012:55-13:45Room DJapanese 
36Eisai Co., LtdWednesday, September 2012:55-13:45Room ETranslated 
to English
37Novartis
Wednesday, September 2012:55-13:45Swan HallEnglish
38Astellas Pharma
Wednesday, September 2012:55-13:45Room B-1Translated 
to English
39Medtronic
Wednesday, September 2012:55-13:45Room B-2English
40Nippon Boehringer Ingelheim Co., Ltd.
Wednesday, September 2013:50- 14:40Room DEnglish
41FUJIFILM RI Pharma Co., Ltd.
Wednesday, September 2013:50- 14:40Room EJapanese 
42Takeda Pharmaceutical
Wednesday, September 20
13:50- 14:40Swan Hall
English
43SANOFI
Wednesday, September 2013:50- 14:40Room B-1Translated 
to English
44Eisai Co., LtdWednesday, September 20
13:50- 14:40Room B-2English
45Nihon Koden
Wednesday, September 20
13:50-14:40
Room H 
English


SUNDAY, SEPTEMBER 17, 2017

SESSION 1:  EARLY DETECTION AND EARLY INTERVENTION OF ALZHEIMER'S DISEASE

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Janssen Pharmaceutical K.K.

Sunday, September 17, 12:55-14:40, Room A [Language: English]  

Chair: Takeshi Ikeuchi (Japan), Kenji Nakashima (Japan)

The Earlier, The Better. Japanese Medical and Social System for Early Detection and Early Intervention of Patients with Alzheimer's Disease

Hisatomo Kowa, Japan

The benefits and challenges of early diagnosis of dementia

Takeshi Ikeuchi, Japan

***************

SESSION 2: CUTTING EDGE OF NEW TREATMENT ON PARKINSON'S DISEASE

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Sumitomo Dainippon Pharma

Sunday, September 17, 12:55-14:40, Annex Hall 2 [Language: Japanese translated to English]  

Chair: Masahiro Nomoto, Japan

From Oxidative Stress and Environmental Toxins to Prion-Like Propagation of Α-Synuclein; A Newly Proposed Pathogenesis of Parkinson's Disease

Makio Takahashi, Japan

Reduced cardiac MIBG Uptake Can be a Potential Biomarker for The Presence of Lewy Bodies

Satoshi Orimo, Japan

Drug Therapy from Japan to The World

Miho Murata, Japan

Panel Discussion: Considering Long-term Prognosis of Patients

***************

SESSION 3: CUTTING EDGE: BIOMARKER OF DISEASE ACTIVITY IN MS

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Novartis

Sunday, September 17, 12:55-13:45, Room D [Language: English]  

Chair Jun-ichi Kira, Japan

Imaging Biomarkers Focusing on q-space Myelin Map

Jin Nakahara, Japan

Molecular Biomarkers Focusing on Neurofilament Light Chain

Jens Kuhle, Switzerland

***************

SESSION 4:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Alexion

Sunday, September 17, 12:55-13:45, Room E [Language: Japanese translated to English]  

Chair: Akio Suzumura, Japan

Overview of  Complement System and Its Role of Pathogenesis In Myasthenia Gravis

Taro Kinoshita, Japan

Current Status and Issues of Myasthenia Gravis Treatment

Kimiaki Utsugisawa, Japan

***************

SESSION 5:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Medtronic

Sunday, September 17, 12:55-13:45, Room B-1 [Language: Japanese]  

Chair: Kenichi Fujimoto, Japan

DBS (Deep Brain Stimulation) from The Referral Physician's Standpoint

Kazuto Yoshida, Japan

Experience of Implementing DBS Therapy into My Practice

Ichiro Yabe, Japan

Panel Discussion

***************

SESSION 6:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Eisai Co., Ltd

Sunday, September 17, 12:55-13:45, Room B-2 [Language: English]  

Chair: Kazutaka Jin, Japan

Epilepsy and Sleep

Manuel Toledo, Spain

************** 

SESSION 7:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Mylan EPD

Sunday, September 17, 13:50-14:40, Room D [Language: Japanese]  

Chair: Masaaki Hirayama, Japan

Up to Date the Management of Chronic Constipation- How to treat constipation of Parkinson's Disease Patients

Atsushi Nakajima, Japan

***************

SESSION 8:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY GlaxoSmithKline

Sunday, September 17, 13:50-14:40, Room E [Language: English]  

Chair: Hiroshi Shibasaki, Japan

Regaining Active Function after Stroke: Botulinum Toxin Therapy with Rehabilitation

Ryuji Kaji, Japan

***************

SESSION 9:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Novartis

Sunday, September 17, 13:50-14:40, Room B-1 [Language: Japanese]  

Chair: Akio Ikeda, Japan

Clinical Condition and Medical Cooperation in Tuberous Sclerosis

Takehiro Ueda, Japan

***************

SESSION 10:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Otsuka Pharmaceutical Co., Ltd. / UCB Japan

Sunday, September 17, 13:50-14:40, Room B-2 [Language: Japanese]  

Chair: Shozo Tobimatsu, Japan

Revised Points of Epilepsy Guideline 2017 of Japanese Society of Neurology

Naoki Akamatsu, Japan

 

MONDAY, SEPTEMBER 18, 2017

SESSION 11:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY GlaxoSmithKline

Monday, September 18, 12:55-13:45, Annex Hall 2 [Language: Japanese]  

Chair: Nobutaka Hattori, Japan

Current Strategy for Management of PD Patients with Medication

Atsushi Takeda, Japan

***************

SESSION 12:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Eli Lilly

Monday, September 18, 12:55-13:45, Room D [Language: Japanese]  

Chair: Yasuomi Ouchi, Japan

Pathological and Molecular Heterogeneity of "Clinically Probable Alzheimer's Disease"

Masahito Yamada, Japan

***************

SESSION 13:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Mitsubishi Tanabe Pharma Corporation

Monday, September 18, 12:55-13:45, Room E [Language: English]  

Chair: Kazutoshi Nishiyama, Japan

Brain Atrophy and Cognitive Impairment in Multiple Sclerosis

Ichiro Nakashima, Japan

***************

SESSION 14:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Pfizer Japan Inc.

Monday, September 18, 12:55-13:45, Swan Hall [Language: English]  

Chair: Yukio Ando, Japan

Current Topics in Amyloidosis from Alzheimer Disease to ATTR Amyloidosis

Yoshiki Sekijima, Japan

***************

SESSION 15:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Daiichi-Sankyo

Monday, September 18, 12:55-13:45, Room B-1 [Language: Japanese]  

Chair: Shun Shimohama, Japan

Neurodegenerative Diseases as Oligomeropath

Kenjiro Ono, Japan

***************

SESSION 16:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Nihon Medi-Physics Co., Ltd.

Monday, September 18, 12:55-13:45, Room B-2 [Language: English]  

Chair: Ryosuke Takahashi, Japan

Construction of Japanese Normal Database for Dopamine Transporter SPECT

Hiroshi Matsuda, Japan

***************

SESSION 17:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY GlaxoSmithKline

Monday, September 18, 13:50-14:40, Annex Hall 2 [Language: English]  

Chair: Naoki Akamatu, Japan

Current Trends in Epilepsy Diagnosis and Treatment

Kazutaka Jin, Japan

***************

SESSION 18:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Bayer Yakuhin, Ltd

Monday, September 18, 13:50-14:40, Room D [Language: Japanese translated to English]  

Chair: Shinichiro Uchiyama, Japan

Management of Acute Stroke Patients with NVAF - Optimal Timing to Start DOAC

Masahiro Yasaka, Japan

***************

SESSION 19: NEW STANDARD OF CARE FOR CRYPTOGENIC STROKE AND ATRIAL FIBRILLATION 

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Medtronic

Monday, September 18, 13:50-14:40, Room E [Language: English]  

Chair: Yoichiro Hashimoto, Japan

The Latest Update on Reveal LINQTM Monitoring - Building Cryptogenic Stroke Pathways

Robert N. Sawyer, Jr., U.S.

ICM for Cryptogenic Stroke Patients in Japan

Kazunori Toyoda, Japan

***************

SESSION 20:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Pfizer Japan Inc./Eisai Co., Ltd

Monday, September 18, 13:50-14:40, Swan Hall [Language: Japanese]  

Chair: Masahiro Sonoo, Japan

Diagnosis and Treatment of Pain in Neuropathy

Yoshiyuki Mitsui, Japan

***************

SESSION 21:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Ono Pharmaceutical

Monday, September 18, 13:50-14:40, Room B-1 [Language: English]  

Chair: Mikio Shoji, Japan

Current Status and Perspectives of Dementia Treatment: A Possibility of BuChE Inhibitor Against Alzheimer's Disease

Makio Takahashi, Japan

***************

SESSION 22:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY InSightec Japan

Monday, September 18, 13:50-14:40, Room B-2 [Language: Japanese]          

Chair: Ritsuko Hanajima, Japan

Treatment of Essential Tremor with Focus Ultrasound

Hideki Mochizuki, Japan

 

TUESDAY, SEPTEMBER 19, 2017

SESSION 23:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Takeda Pharmaceutical

Tuesday, September 19, 12:55-13:45, Annex Hall 2 [Language: Japanese translated to English]  

Chair: Hideki Mochizuki, Japan

Diagnosis of Parkinson's Disease: Past, Present and Future

Kazushi Takahashi, Japan

***************

SESSION 24:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Mitsubishi Tanabe Pharma Corporation

Tuesday, September 19, 12:55-14:40, Room D [Language: English]  

Chair: Gen Sobue (Japan), Satoshi Kaneko (Japan)

Perspective of ALS Therapy from New Molecular Mechanism

Osamu Onodera, Japan

Gene Therapy Against Spinocerebellar Ataxia

Hitoshi Okazawa, Japan

***************

SESSION 25:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Pfizer Japan Inc.

Tuesday, September 19, 12:55-13:45, Room E [Language: Japanese]  

Chair: Yasuo Terayama, Japan

Management for Intractable or Puzzling Headaches - How to Diagnose and How to Treat

Shinya Manaka, Japan

***************

SESSION 26: ANTICOAGULATION

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Bristol-Myers Squibb / Pfizer Japan Inc.

Tuesday, September 19, 12:55-13:45, Swan Hall [Language: Japanese translated to English]  

Chair: Norihiro Suzuki, Japan

Mechanisms of Thrombus Formation

Yujiro Asada, Japan

Anticoagulant Therapy for Stroke – Focus on Important Deep Vein Thrombosis in Clinical Field

Hidetaka Mitsumura, Japan

***************

SESSION 27:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Nihon Pharmaceutical Co.,LTD.

Tuesday, September 19, 12:55-13:45, Room B-1 [Language: English]  

Chair: Ryuji Kaji, Japan

CIDP: Update 2017, and Maintenance IVIg Treatment

Satoshi Kuwabara, Japan


***************

SESSION 28:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Daiichi-Sankyo / UCB Japan

Tuesday, September 19, 12:55-13:45, Room B-2 [Language: Japanese]

Chair: Sadatoshi Tsuji, Japan

Ictal Semiology for Accurate Diagnosis of Epilepsy

Riki Matsumoto, Japan

***************

SESSION 29:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Eli Lilly

Tuesday, September 19, 12:55-13:45, Room H [Language: Japanese]  

Chair: Hiroyuki Arai, Japan

Making an Accurate Diagnosis with Experts: A Hands-On Seminar for Clinical, Imaging and Pathological Diagnosis on Dementia

Kenji Ishii (Japan) and Hiroshi Matsuda (Japan)

***************

SESSION 30:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Kyowa Hakko Kirin

Tuesday, September 19, 13:50-14:40, Annex Hall 2 [Language: Japanese]  

Chair: Yoshikazu Ugawa, Japan

Clinical Practice Guideline for Parkinson's Disease in Japan

Kenichi Kashihara, Japan

***************

SESSION 31: WHAT ENDOVASCULAR THERAPY CAN DO FOR ACUTE ISCHEMIC STROKE?

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Stryker Japan K.K.

Tuesday, September 19, 13:50-14:40, Swan Hall [Language: Japanese translated to English]  

Chair: Kazunori Toyoda, Japan

Approaches to the endovascular therapy for ischemic stroke from the standpoint of stroke neurologist

Tatsuo Amano, Japan

Toward the Elimination of Disparities in Endovascular Treatment of Acute Ischemic Stroke

Shinichi Yoshimura, Japan

***************

SESSION 32: STATE OF THE ART; VASCULITIC PERIPHERAL NEUROPATHY

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Teijin Pharma Limited

Tuesday, September 19, 13:50-14:40, Room B-1 [Language: Japanese translated to English]  

Chair: Takashi Kanda, Japan

Intravenous Immunoglobin (IVIG): Clinical Efficacy and Mechanisms in Systemic Vasculitis as Especially Eosinophilic Granulomatosis with Polyangiitis

Naomi Tsurikisawa, Japan

Diagnosis and Management of Vasculitic Neuropathy

Haruki Koike, Japan

***************

SESSION 33:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Quanterix Corporation / Scrum

Tuesday, September 19, 13:50-14:40, Room B-2 [Language: English]  

Chair: Takahiko Tokuda, Japan

New Era of Neurodegenerative Disease Biomarker Research and Diagnosis, Empowered by Single-Molecule Array (Simoa) Technology

Naomi Tsurikisawa, Japan

Diagnosis and Management of Vasculitic Neuropathy

Andreas Jeromin, US


WEDNESDAY, SEPTEMBER 20, 2017 


SESSION 34: NEW MOVEMENT NEW HORIZON FOR DEVICE AIDED THERAPIES IN JAPAN

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY AbbVie GK

Wednesday, September 20, 12:55-14:40, Annex Hall 2 [Language: English]  

Chairs: Satoshi Orimo (Japan), Atsushi Takeda (Japan)

aPD Treatment and 5-2-1 Concept

Angelo Antonini, Italy

Clinical Experience of DAT in Juntendo Univ.

Yasushi Shimo (Japan), Taku Hatano (Japan), Genko Oyama (Japan)

Commentator:

Nobutaka Hattori (Japan), Yoshikazu Ugawa (Japan)        

***************

SESSION 35:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Otsuka Pharmaceutica Co., Ltd.

Wednesday, September 20, 12:55-13:45, Room D [Language: Japanese]  

Chair: Miho Murata, Japan

Human Neurophysiology and Anti-Parkinson Drugs

Ritsuko Hanajima, Japan

***************

SESSION 36:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Eisai Co., Ltd

Wednesday, September 20, 12:55-13:45, Room E [Language: Japanese translated to English]  

Chair: Etsuro Matsubara, Japan

Dementia with Lewy Bodies: An Update

Esturo Mori, Japan

 

***************

SESSION 37:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Novartis

Wednesday, September 20, 12:55-13:45, Swan Hall [Language: English]  

Chair: Takeshi Iwatsubo, Japan

Addressing Mechanisms of Neurodegenerative and Neurodevelopmental Disorders

Daniel Curtis, US

***************

SESSION 38:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Astellas Pharma

Wednesday, September 20, 12:55-13:45, Room B-1 [Language: Japanese translated to English]  

Chair: Koichi Hirata, Japan

Treatment Strategy of Restless Legs Syndrome

Yuichi Inoue, Japan

***************

SESSION 39:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Medtronic

Wednesday, September 20, 12:55-13:45, Room B-2 [Language: English]  

Chair: Masayasu Matsumoto, Japan

Current Status of Mechanical Thrombectomy and Role of Neurologists for Acute Ischemic Stroke in Japan

Teruyuki Hirano (Japan), Yuji Matsumaru(Japan)

***************

SESSION 40:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Nippon Boehringer Ingelheim Co., Ltd.

Wednesday, September 20, 13:50-14:40, Room D [Language: English]  

Chair: Masayasu Matsumoto, Japan

Advances of Imaging Analysis in Parkinson's Disease

Hirohisa Watanabe, Japan

***************

SESSION 41:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY FUJIFILM RI Pharma Co., Ltd.

Wednesday, September 20, 13:50-14:40, Room E [Language: Japanese]  

Chair: Toshiki Mizuno, Japan

Dementia Imaging Diagnosis UPDATE - Role of Cerebral Blood Flow SPECT and Amyloid Imaging

Noriyuki Kimura, Japan

***************

SESSION 42:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Takeda Pharmaceutical

Wednesday, September 20, 13:50-14:40, Swan Hall [Language: English]  

Chair: Kazuo Fujihara, Japan

Transrational Research Towards Understanding the Pathogenesis of MS/NMO

Takashi Yamamura, Japan

***************

SESSION 43:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY SANOFI

Wednesday, September 20, 13:50-14:40, Room B-1 [Language: Japanese translated to English]  

Chair: Hidehiro Mizusawa, Japan

Paradigm Shift of Drug Discovery Research for ALS

Gen Sobue, Japan

Essence of Patient Care Not Covered in ALS Guideline

Mieko Ogino, Japan

***************

SESSION 44:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Eisai Co., Ltd

Wednesday, September 20, 13:50-14:40, Room B-2 [Language: English]  

Chair: Riki Matsumoto, Japan

AMPA Receptor Disorders

Takuya Takahashi, Japan

***************

SESSION 45:

SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Nihon Koden

Wednesday, September 20, 13:50-14:40, Room H [Language: English]  

Chair: Kohara Nobuo, Japan

Baisc Principles and Practice of F‐wave & Blinkreflex

Jun Kimura, US